Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Free Cash Flow Generation Index

Latest as of December 2024: -0.06x

Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Free Cash Flow Generation Index of -0.06x as of December 2024. Free cash flow of CN¥-7.20 Million represents 0% of operating cash flow (CN¥122.51 Million). Read Nanjing Medlander Medical Technology Co. (688273) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

-0.06x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-7.20 Million
CNY

Operating Cash Flow

CN¥122.51 Million
CNY

Capital Expenditures

CN¥129.71 Million
CNY

Nanjing Medlander Medical Technology Co. Ltd. A Free Cash Flow Generation Index (2020–2024)

Historical FCF Generation Index trend for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. Explore Nanjing Medlander Medical Technology Co. (688273) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)

Year-by-year Free Cash Flow Generation Index for Nanjing Medlander Medical Technology Co. Ltd. A. For the full company profile including market capitalisation, see Nanjing Medlander Medical Technology Co. stock valuation.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -0.06x CN¥-7.20 Million CN¥122.51 Million CN¥129.71 Million ▼ -113.0%
2023 0.45x CN¥61.76 Million CN¥136.91 Million CN¥75.15 Million ▼ -21.1%
2022 0.57x CN¥72.41 Million CN¥126.67 Million CN¥54.26 Million ▼ -36.6%
2021 0.90x CN¥134.01 Million CN¥148.60 Million CN¥14.58 Million ▲ +12.4%
2020 0.80x CN¥105.18 Million CN¥131.10 Million CN¥25.91 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).